Scilex Holding (SCLX) Receivables - Net (2021 - 2026)
Scilex Holding (SCLX) posted quarterly Receivables - Net of $10.6 million for Q1 2026, little changed year-over-year from $10.6 million in Q1 2025, and down 10.84% quarter-over-quarter from $11.9 million in Q3 2025.
Scilex Holding (SCLX) Receivables - Net (2021 - 2026) Analysis & Trends
Scilex Holding's Receivables - Net history runs 6 years deep, the most recent figure standing at $10.6 million for Q1 2026.
- In Q1 2026, Receivables - Net changed 0.26% year-over-year to $10.6 million; the TTM figure through Mar 2026 stood at $10.6 million (changed 0.26% YoY), while the FY2024 annual figure was $26.4 million, down 23.57% from the prior year.
- Receivables - Net for Q1 2026 stood at $10.6 million, down from $11.9 million in the prior quarter.
- The five-year high for Receivables - Net was $38.0 million in Q2 2024, with the low at $10.6 million in Q1 2025.
- The 5-year median for Receivables - Net is $21.2 million (2022), against an average of $22.7 million.
- The sharpest annual moves came in 2024 and 2025: Receivables - Net surged 92.23% in 2024, then plunged 64.27% in 2025.
- Scilex Holding's Receivables - Net stood at $21.2 million in 2022, then soared by 62.92% to $34.6 million in 2023, then retreated by 23.57% to $26.4 million in 2024, then sank by 54.84% to $11.9 million in 2025, then declined by 10.84% to $10.6 million in 2026.
- Business Quant data shows SCLX's Receivables - Net at $10.6 million in Q1 2026, $11.9 million in Q3 2025, and $16.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.91 Bn | 632.15 Bn | 17.26 Bn |
| 2 | AbbVie | 469.40 Bn | 462.83 Bn | 12.70 Bn |
| 3 | Merck | 375.75 Bn | 368.61 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.13 Bn | 295.44 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.65 Bn | 252.75 Bn | 12.86 Bn |
| 6 | Amgen | 236.26 Bn | 222.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 182.12 Bn | 178.95 Bn | 6.22 Bn |
| 8 | Pfizer | 159.46 Bn | 147.76 Bn | 10.94 Bn |
| 9 | Gsk | 106.21 Bn | 102.04 Bn | 8.24 Bn |
| 10 | Scilex Holding | 39.10 Mn | -73.69 Mn | 3.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.65 Mn |
| Mar 31, 2026 | 10.65 Mn |
| Sep 30, 2025 | 11.94 Mn |
| Sep 30, 2025 | 11.94 Mn |
| Jun 30, 2025 | 16.77 Mn |
| Jun 30, 2025 | 16.77 Mn |
| Mar 31, 2025 | 10.62 Mn |
| Mar 31, 2025 | 10.62 Mn |
| Dec 31, 2024 | 26.44 Mn |
| Dec 31, 2024 | 26.44 Mn |
| Sep 30, 2024 | 31.58 Mn |
| Sep 30, 2024 | 31.58 Mn |
| Jun 30, 2024 | 38.00 Mn |
| Jun 30, 2024 | 38.00 Mn |
| Mar 31, 2024 | 29.72 Mn |
| Mar 31, 2024 | 29.72 Mn |
| Dec 31, 2023 | 34.60 Mn |
| Dec 31, 2023 | 34.60 Mn |
| Sep 30, 2023 | 16.43 Mn |
| Sep 30, 2023 | 16.43 Mn |